Abstract
Microangiopathic haemolytic anaemia (MAHA) is a well recognized complication of disseminated carcinoma and its treatment. It is however, rarely seen with localized carcinoma. The case presented here is a previously unreported association of a patient, who having been successfully treated for MAHA, was found to have occult breast carcinoma on a routine screening mammogram six months after the haemolytic episode.
MeSH terms
-
Adenocarcinoma / blood
-
Adenocarcinoma / complications*
-
Adenocarcinoma / diagnostic imaging
-
Anemia, Hemolytic / complications*
-
Anemia, Hemolytic / drug therapy
-
Anemia, Hemolytic / therapy
-
Breast Neoplasms / blood
-
Breast Neoplasms / complications*
-
Breast Neoplasms / diagnostic imaging
-
Dexamethasone / therapeutic use
-
Epoprostenol / therapeutic use
-
Female
-
Humans
-
Middle Aged
-
Neoplasms, Unknown Primary / blood
-
Neoplasms, Unknown Primary / complications*
-
Plasma Exchange
-
Pneumonia / complications
-
Radiography
-
Vincristine / therapeutic use
Substances
-
Vincristine
-
Dexamethasone
-
Epoprostenol